UBS Group’s Niki BioSolutions NIKI Stock Holding History

UBS Group’s Portfolio NIKI Stock Details NIKI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.8K	Buy	+2,198	New	+$16.2K	﹤0.01%	9015

Other funds holding NIKI

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

UBS Group's NIKI Position: Q3 2026 in Review

UBS Group opened a new position in Niki BioSolutions (NIKI) in Q3 2026: 2,198 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #9015 among its holdings.

2 funds tracked by Wall St. Rank hold NIKI as of Q3 2026.

UBS Group held 2,198 shares of Niki BioSolutions worth $10.8K as of Q3 2026.
Niki BioSolutions was a new UBS Group position in Q3 2026.
Niki BioSolutions made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #9015 holding.
2 funds tracked by Wall St. Rank held Niki BioSolutions as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.